LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Home・Stock List・Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Closed

Sector Healthcare

318.7 1.09

Buy Sell

Overview

Share price change

24h

Current

Min

311.86

Max

322.49

Key metrics
By Trading Economics
Income	34M 384M
Sales	-70M 611M
EPS	2.29
Profit margin	62.855
Employees	8,030
EBITDA	404M 540M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+11.21 upside

Dividends
By Dow Jones
Next Earnings	1 Aug 2024

Market Stats
By TradingEconomics
Market Cap	1.1B 8.8B
Previous open	317.61
Previous close	318.7

News Sentiment

By Acuity

50%

123 / 369 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

312.43 / 323.17 Support & Resistance

Bio-Rad Laboratories Inc Chart

Related News

25 Jul 2024, 20:16 UTC

Earnings

Norfolk Southern Grows 2Q Profit, Seeks to Leave Behind Derailment Tailwinds

25 Jul 2024, 22:57 UTC

Earnings

Minas Buenaventura 2Q Net $74.4M >BVN

25 Jul 2024, 22:10 UTC

Earnings

Berkshire Is Quickly Cutting Its Stake in Bank of America. More Sales Could Be Coming. -- Barrons.com

25 Jul 2024, 21:59 UTC

Market Talk

Earnings

Global Energy Roundup: Market Talk

25 Jul 2024, 21:59 UTC

Market Talk

Earnings

Norfolk Southern Lowers Operating Ratio in 2Q, Shares Jump -- Market Talk

25 Jul 2024, 21:51 UTC

Earnings

Update: Berkshire Is Quickly Cutting Its Stake in Bank of America. More Sales Could Be Coming. -- Barrons.com

25 Jul 2024, 21:32 UTC

Acquisitions, Mergers, Takeovers

Noble: Special Meeting of Diamond Stockholders to Vote on Transaction Is Currently Scheduled for Aug 27 >NE

25 Jul 2024, 21:32 UTC

Acquisitions, Mergers, Takeovers

Noble Corp and Diamond Offshore: Announce Expiration of Hart-Scott-Rodino Act Waiting Period and Provide Transaction Update

25 Jul 2024, 21:18 UTC

Earnings

A.J. Gallagher Earnings Show Insurance Brokers Are Anything but Humdrum -- Barrons.com

25 Jul 2024, 21:11 UTC

Peer Comparison

Price change

Bio-Rad Laboratories Inc Forecast

Price Target

By TipRanks

11.21% upside

12 Months Forecast

Average 350.5 USD 11.21%

High 402 USD

Low 300 USD

Based on 4 Wall Street analysts offering 12 month price targets forBio-Rad Laboratories Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Based on 4 analysts giving stock ratings to Bio-Rad Laboratories Inc - Dist in the past 3 months.

Technical Score

By Trading Central

312.43 / 323.17Support & Resistance

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Sentiment

By Acuity

123 / 369 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.